Showing 1 posts of 1 posts found.
Biophytis has announced that it has received investigational new drug (IND) approval from the US Food and Drug Administration (FDA) …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO